275 related articles for article (PubMed ID: 11742995)
1. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.
Kitabayashi I; Aikawa Y; Nguyen LA; Yokoyama A; Ohki M
EMBO J; 2001 Dec; 20(24):7184-96. PubMed ID: 11742995
[TBL] [Abstract][Full Text] [Related]
2. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.
Kitabayashi I; Yokoyama A; Shimizu K; Ohki M
EMBO J; 1998 Jun; 17(11):2994-3004. PubMed ID: 9606182
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators.
Chen CJ; Deng Z; Kim AY; Blobel GA; Lieberman PM
Mol Cell Biol; 2001 Jan; 21(2):476-87. PubMed ID: 11134336
[TBL] [Abstract][Full Text] [Related]
4. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
[TBL] [Abstract][Full Text] [Related]
5. MOZ-TIF2 alters cofactor recruitment and histone modification at the RARbeta2 promoter: differential effects of MOZ fusion proteins on CBP- and MOZ-dependent activators.
Collins HM; Kindle KB; Matsuda S; Ryan C; Troke PJF; Kalkhoven E; Heery DM
J Biol Chem; 2006 Jun; 281(25):17124-17133. PubMed ID: 16613851
[TBL] [Abstract][Full Text] [Related]
6. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).
Panagopoulos I; Isaksson M; Lindvall C; Björkholm M; Ahlgren T; Fioretos T; Heim S; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2000 Aug; 28(4):415-24. PubMed ID: 10862050
[TBL] [Abstract][Full Text] [Related]
7. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
[TBL] [Abstract][Full Text] [Related]
9. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.
Borrow J; Stanton VP; Andresen JM; Becher R; Behm FG; Chaganti RS; Civin CI; Disteche C; Dubé I; Frischauf AM; Horsman D; Mitelman F; Volinia S; Watmore AE; Housman DE
Nat Genet; 1996 Sep; 14(1):33-41. PubMed ID: 8782817
[TBL] [Abstract][Full Text] [Related]
10. Physical and functional link of the leukemia-associated factors AML1 and PML.
Nguyen LA; Pandolfi PP; Aikawa Y; Tagata Y; Ohki M; Kitabayashi I
Blood; 2005 Jan; 105(1):292-300. PubMed ID: 15331439
[TBL] [Abstract][Full Text] [Related]
11. MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.
Kindle KB; Troke PJ; Collins HM; Matsuda S; Bossi D; Bellodi C; Kalkhoven E; Salomoni P; Pelicci PG; Minucci S; Heery DM
Mol Cell Biol; 2005 Feb; 25(3):988-1002. PubMed ID: 15657427
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.
Bristow CA; Shore P
Nucleic Acids Res; 2003 Jun; 31(11):2735-44. PubMed ID: 12771199
[TBL] [Abstract][Full Text] [Related]
13. Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.
Johnson KD; Norton JE; Bresnick EH
Nucleic Acids Res; 2002 Apr; 30(7):1522-30. PubMed ID: 11917012
[TBL] [Abstract][Full Text] [Related]
14. The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivator.
Harton JA; Zika E; Ting JP
J Biol Chem; 2001 Oct; 276(42):38715-20. PubMed ID: 11514574
[TBL] [Abstract][Full Text] [Related]
15. E protein silencing by the leukemogenic AML1-ETO fusion protein.
Zhang J; Kalkum M; Yamamura S; Chait BT; Roeder RG
Science; 2004 Aug; 305(5688):1286-9. PubMed ID: 15333839
[TBL] [Abstract][Full Text] [Related]
16. The acetyltransferase activity of CBP stimulates transcription.
Martinez-Balbás MA; Bannister AJ; Martin K; Haus-Seuffert P; Meisterernst M; Kouzarides T
EMBO J; 1998 May; 17(10):2886-93. PubMed ID: 9582282
[TBL] [Abstract][Full Text] [Related]
17. PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner.
Jiang H; Lu H; Schiltz RL; Pise-Masison CA; Ogryzko VV; Nakatani Y; Brady JN
Mol Cell Biol; 1999 Dec; 19(12):8136-45. PubMed ID: 10567539
[TBL] [Abstract][Full Text] [Related]
18. The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation.
Deng Z; Chen CJ; Chamberlin M; Lu F; Blobel GA; Speicher D; Cirillo LA; Zaret KS; Lieberman PM
Mol Cell Biol; 2003 Apr; 23(8):2633-44. PubMed ID: 12665567
[TBL] [Abstract][Full Text] [Related]
19. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter.
Zhang DE; Hetherington CJ; Meyers S; Rhoades KL; Larson CJ; Chen HM; Hiebert SW; Tenen DG
Mol Cell Biol; 1996 Mar; 16(3):1231-40. PubMed ID: 8622667
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
